Llwytho...
Preclinical evaluation of mesenchymal stem cells overexpressing VEGF to treat critical limb ischemia
Numerous clinical trials are utilizing mesenchymal stem cells (MSC) to treat critical limb ischemia, primarily for their ability to secrete signals that promote revascularization. These cells have demonstrated clinical safety, but their efficacy has been limited, possibly because these paracrine sig...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Mol Ther Methods Clin Dev |
|---|---|
| Prif Awduron: | , , , , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Nature Publishing Group
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5003097/ https://ncbi.nlm.nih.gov/pubmed/27610394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mtm.2016.53 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|